CRML

SEC Filing Summary: Critical Metals Corp. (CRML)

Business Context and Reporting Period

Company: Critical Metals Corp. (CRML)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended June 30, 2024
Jurisdiction: British Virgin Islands (Foreign Private Issuer)
Accounting Standard: International Financial Reporting Standards (IFRS)

Critical Metals Corp. is a mining development company focused on critical metals, primarily lithium and rare earths. The company became a publicly traded entity on the Nasdaq Capital Market on February 28, 2024, following a business combination with Sizzle Acquisition Corp. Its primary assets are the Wolfsberg Lithium Project in Austria and the Tanbreez Rare Earths Project in Greenland. The company is currently in the exploration and development stage with no commercial production or operating revenue.

Key Financial Metrics (Year Ended June 30, 2024)

Note: The significant net loss is driven by non-cash listing expenses ($77.3 million), merger expenses ($9.4 million), and a loss on the fair value of warrants ($20.6 million).

Material Changes vs. Prior Period

• Business Combination: The company completed a merger with Sizzle Acquisition Corp. in February 2024, transitioning from a private entity to a Nasdaq-listed company (Ticker: CRML).
• Asset Acquisition: Acquired a 5.55% interest in the Tanbreez Project (Greenland) for $5.0 million in cash. Subsequent to year-end, this stake increased to 42% via share issuance.
• Offtake Agreement: Received a $15.0 million advance payment from BMW for future lithium hydroxide deliveries. These funds are restricted and held in a deposit account secured by a bank guarantee.
• Financial Position: Total liabilities increased from $3.3 million in 2023 to $78.5 million in 2024, primarily due to the recognition of warrant liabilities ($45.9 million) and trade payables related to the business combination.
• Equity Structure: Share capital increased significantly due to the issuance of shares to European Lithium Limited (EUR), PIPE investors, and vendors in connection with the merger.

Guidance, Outlook, Risks, and Contingencies

Going Concern Warning

The filing explicitly states that substantial doubt exists regarding the company's ability to continue as a going concern within one year. The company has a working capital deficit, recurring net losses, and limited unrestricted cash ($1.3 million). Continued operations depend entirely on raising additional capital, which is not guaranteed.

Outlook and Strategy

• Production Timeline: Spodumene production at the Wolfsberg Project is targeted for 2026 or 2027, subject to funding and regulatory approvals.
• Financing: The company has a $125 million equity line of credit (GEM Agreement) but has not drawn down on it. It is actively seeking equity or debt financing.
• Joint Venture: Entered a joint venture with Obeikan Investment Group to build a lithium hydroxide processing plant in Saudi Arabia.

Key Risks and Contingencies

• Internal Controls: The company identified six significant deficiencies in internal control over financial reporting, including lack of segregation of duties, inadequate accounting for related party transactions, and insufficient cybersecurity programs.
• Regulatory & Permitting: Development of the Wolfsberg and Tanbreez projects is contingent on obtaining complex governmental permits in Austria and Greenland, which are time-consuming and uncertain.
• Commodity Prices: Future profitability is highly sensitive to lithium and rare earth prices, which are volatile.
• Warrant Liability: The company has significant warrant liabilities ($45.9 million) that are re-measured at fair value each period, creating volatility in the income statement.

Investor Verification Checklist

• Liquidity Runway: Verify the company's current cash burn rate and the status of any new financing agreements post-filing to assess the immediate risk of insolvency.
• Internal Control Remediation: Review management's specific plan and timeline for remedying the six identified significant deficiencies in internal controls.
• BMW Offtake Terms: Confirm the specific conditions required to access the $15.0 million restricted cash and the timeline for product qualification.
• Tanbreez Acquisition: Verify the completion of the Stage 1 acquisition (increasing stake to 42%) and the terms for the potential Stage 2 acquisition (up to 92.5%).
• Warrant Exercise: Monitor the market price of CRML shares relative to warrant exercise prices ($10.00 - $11.50) to assess potential dilution or cash inflows from warrant exercises.